Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.

Brockwell NK, Rautela J, Owen KL, Gearing LJ, Deb S, Harvey K, Spurling A, Zanker D, Chan CL, Cumming HE, Deng N, Zakhour JM, Duivenvoorden HM, Robinson T, Harris M, White M, Fox J, Ooi C, Kumar B, Thomson J, Potasz N, Swarbrick A, Hertzog PJ, Molloy TJ, Toole SO, Ganju V, Parker BS.

NPJ Precis Oncol. 2019 Aug 29;3:21. doi: 10.1038/s41698-019-0093-2. eCollection 2019.

2.

A niche-dependent myeloid transcriptome signature defines dormant myeloma cells.

Khoo WH, Ledergor G, Weiner A, Roden DL, Terry RL, McDonald MM, Chai RC, De Veirman K, Owen KL, Opperman KS, Vandyke K, Clark JR, Seckinger A, Kovacic N, Nguyen A, Mohanty ST, Pettitt JA, Xiao Y, Corr AP, Seeliger C, Novotny M, Lasken RS, Nguyen TV, Oyajobi BO, Aftab D, Swarbrick A, Parker B, Hewett DR, Hose D, Vanderkerken K, Zannettino ACW, Amit I, Phan TG, Croucher PI.

Blood. 2019 Jul 4;134(1):30-43. doi: 10.1182/blood.2018880930. Epub 2019 Apr 25.

PMID:
31023703
3.

Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis.

Owen KL, Parker BS.

Mol Immunol. 2019 Jun;110:57-68. doi: 10.1016/j.molimm.2017.11.023. Epub 2017 Nov 27. Review.

PMID:
29191489
4.

Neoadjuvant Interferons: Critical for Effective PD-1-Based Immunotherapy in TNBC.

Brockwell NK, Owen KL, Zanker D, Spurling A, Rautela J, Duivenvoorden HM, Baschuk N, Caramia F, Loi S, Darcy PK, Lim E, Parker BS.

Cancer Immunol Res. 2017 Oct;5(10):871-884. doi: 10.1158/2326-6066.CIR-17-0150. Epub 2017 Aug 28.

5.

A case-control study to identify risk factors for acute salmonellosis in New Zealand dairy herds, 2011-2012.

Stevenson MA, Morgan PL, Sanhueza J, Oakley GE, Bateman RS, McFADDEN A, MacPHERSON N, Owen KL, Burton L, Walsh S, Weston J, Marchant R.

Epidemiol Infect. 2016 Jul;144(10):2154-64. doi: 10.1017/S095026881600042X. Epub 2016 Mar 9.

PMID:
26956947
6.

Role of phosphoinositide 3-kinases in regulating cardiac function.

Pretorius L, Owen KL, McMullen JR.

Front Biosci (Landmark Ed). 2009 Jan 1;14:2221-9. Review.

PMID:
19273196
7.

The protective effects of exercise and phosphoinositide 3-kinase (p110alpha) in the failing heart.

Owen KL, Pretorius L, McMullen JR.

Clin Sci (Lond). 2009 Mar;116(5):365-75. doi: 10.1042/CS20080183. Review.

PMID:
19175355
8.

Promoting physiological hypertrophy in the failing heart.

Pretorius L, Owen KL, Jennings GL, McMullen JR.

Clin Exp Pharmacol Physiol. 2008 Apr;35(4):438-41. doi: 10.1111/j.1440-1681.2008.04893.x. Review.

PMID:
18307737
9.

The impact of a blended learning approach on instructor and learner satisfaction with preceptor education.

Bradley C, Erice M, Halfer D, Jordan K, Lebaugh D, Opperman C, Owen KL, Stephen J.

J Nurses Staff Dev. 2007 Jul-Aug;23(4):164-70; quiz 171-2.

PMID:
17666898
10.

Embarking on a journey: Implementing bar coding.

Carroll KA, Owen KL, Ward M.

Comput Inform Nurs. 2006 Sep-Oct;24(5):248-53. No abstract available.

PMID:
16980775
11.

Recombinant interleukin-2 therapy of systemic lupus erythematosus in the New Zealand black/New Zealand white mouse.

Owen KL, Shibata T, Izui S, Walker SE.

J Biol Response Mod. 1989 Aug;8(4):366-74.

PMID:
2666586

Supplemental Content

Support Center